Abstract
PurposeA major limitation of biologic therapy is formation of anti-drug antibodies (ADA). We have demonstrated ADA to Rituximab (RTX) predict subsequent infusion related reactions. However, little is known regarding the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
